Free Trial
NASDAQ:INVO

INVO Bioscience (INVO) Stock Price, News & Analysis

INVO Bioscience logo
$0.78 -0.04 (-5.39%)
As of 07/11/2025

About INVO Bioscience Stock (NASDAQ:INVO)

Key Stats

Today's Range
$0.76
$0.85
50-Day Range
$0.81
$2.33
52-Week Range
$0.63
$3.50
Volume
176,733 shs
Average Volume
1.59 million shs
Market Capitalization
$2.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

INVO Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
NAYA Biosciences Inc trading halted, news pending
NAYA Biosciences to effect 1-for-12 reverse split
See More Headlines

INVO Stock Analysis - Frequently Asked Questions

INVO Bioscience's stock was trading at $0.81 on January 1st, 2025. Since then, INVO stock has decreased by 4.2% and is now trading at $0.7758.

INVO Bioscience, Inc. (NASDAQ:INVO) posted its quarterly earnings results on Monday, November, 15th. The company reported ($4.80) earnings per share for the quarter, missing analysts' consensus estimates of ($4.00) by $0.80. The company had revenue of $0.22 million for the quarter, compared to analyst estimates of $0.25 million.

INVO Bioscience's stock reverse split before market open on Thursday, July 27th 2023.The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that INVO Bioscience investors own include NVIDIA (NVDA), NIO (NIO), Tesla (TSLA), Meta Platforms (META), Nikola (NKLA), Broadcom (AVGO) and Bilibili (BILI).

Company Calendar

Last Earnings
11/15/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:INVO
CIK
1417926
Fax
N/A
Employees
25
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.03 million
Net Margins
-122.79%
Pretax Margin
-122.32%
Return on Equity
N/A
Return on Assets
-36.94%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.30
Quick Ratio
0.27

Sales & Book Value

Annual Sales
$5.77 million
Price / Sales
0.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.06) per share
Price / Book
-0.38

Miscellaneous

Outstanding Shares
3,809,000
Free Float
3,769,000
Market Cap
$2.96 million
Optionable
No Data
Beta
1.43
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:INVO) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners